Abstract
Single-arm clinical trials are useful to evaluate antiretroviral regimens in certain populations of HIV-infected treatment-naive patients for whom a randomized controlled trial is not feasible or desirable. They can also be useful to establish initial estimates of efficacy and safety/tolerability of novel regimens to inform the design of large phase III trials. In this article, we discuss key design considerations for such single-arm studies.
Original language | English (US) |
---|---|
Pages (from-to) | 652-657 |
Number of pages | 6 |
Journal | AIDS research and human retroviruses |
Volume | 29 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2013 |
ASJC Scopus subject areas
- Infectious Diseases
- Virology
- Immunology